247 related articles for article (PubMed ID: 26033252)
1. Antifungal stewardship in daily practice and health economic implications.
Muñoz P; Valerio M; Vena A; Bouza E
Mycoses; 2015 Jun; 58 Suppl 2():14-25. PubMed ID: 26033252
[TBL] [Abstract][Full Text] [Related]
2. Antifungal stewardship in a tertiary-care institution: a bedside intervention.
Valerio M; Muñoz P; Rodríguez CG; Caliz B; Padilla B; Fernández-Cruz A; Sánchez-Somolinos M; Gijón P; Peral J; Gayoso J; Frias I; Salcedo M; Sanjurjo M; Bouza E;
Clin Microbiol Infect; 2015 May; 21(5):492.e1-9. PubMed ID: 25748494
[TBL] [Abstract][Full Text] [Related]
3. New antifungal agents for the treatment of candidaemia.
Muñoz P; Guinea J; Rojas L; Bouza E
Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S63-9. PubMed ID: 21129925
[TBL] [Abstract][Full Text] [Related]
4. The case for antifungal stewardship.
Ananda-Rajah MR; Slavin MA; Thursky KT
Curr Opin Infect Dis; 2012 Feb; 25(1):107-15. PubMed ID: 22123667
[TBL] [Abstract][Full Text] [Related]
5. Training should be the first step toward an antifungal stewardship program.
Valerio M; Muñoz P; Rodríguez-González C; Sanjurjo M; Guinea J; Bouza E;
Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):221-7. PubMed ID: 25066382
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of candidemia and invasive candidiasis according to guidelines].
Glöckner A
Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
[TBL] [Abstract][Full Text] [Related]
7. Impact of a non-compulsory antifungal stewardship program on overuse and misuse of antifungal agents in a tertiary care hospital.
Markogiannakis A; Korantanis K; Gamaletsou MN; Samarkos M; Psichogiou M; Daikos G; Sipsas NV
Int J Antimicrob Agents; 2021 Jan; 57(1):106255. PubMed ID: 33279582
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed.
Valerio M; Rodriguez-Gonzalez CG; Muñoz P; Caliz B; Sanjurjo M; Bouza E;
J Antimicrob Chemother; 2014 Jul; 69(7):1993-9. PubMed ID: 24659750
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.
Pfaller MA; Castanheira M
Med Mycol; 2016 Jan; 54(1):1-22. PubMed ID: 26385381
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the impact of antifungal stewardship interventions in the United States.
Hart E; Nguyen M; Allen M; Clark CM; Jacobs DM
Ann Clin Microbiol Antimicrob; 2019 Aug; 18(1):24. PubMed ID: 31434563
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010-16.
Whitney L; Al-Ghusein H; Glass S; Koh M; Klammer M; Ball J; Youngs J; Wake R; Houston A; Bicanic T
J Antimicrob Chemother; 2019 Jan; 74(1):234-241. PubMed ID: 30376118
[TBL] [Abstract][Full Text] [Related]
12. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
13. Trends in antifungal use in US hospitals, 2006-12.
Vallabhaneni S; Baggs J; Tsay S; Srinivasan AR; Jernigan JA; Jackson BR
J Antimicrob Chemother; 2018 Oct; 73(10):2867-2875. PubMed ID: 30295769
[TBL] [Abstract][Full Text] [Related]
14. Impact of education and an antifungal stewardship program for candidiasis at a Thai tertiary care center.
Apisarnthanarak A; Yatrasert A; Mundy LM;
Infect Control Hosp Epidemiol; 2010 Jul; 31(7):722-7. PubMed ID: 20497042
[TBL] [Abstract][Full Text] [Related]
15. Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013.
Fondevilla E; Grau S; Mojal S; Palomar M; Matas L; Gudiol F;
Expert Rev Anti Infect Ther; 2016; 14(1):137-44. PubMed ID: 26466197
[TBL] [Abstract][Full Text] [Related]
16. An investigation of antifungal stewardship programmes in England.
Micallef C; Ashiru-Oredope D; Hansraj S; Denning DW; Agrawal SG; Manuel RJ; Schelenz S; Guy R; Muller-Pebody B; Patel R; Howard P; Hopkins S; Johnson E; Enoch DA
J Med Microbiol; 2017 Nov; 66(11):1581-1589. PubMed ID: 29068278
[TBL] [Abstract][Full Text] [Related]
17. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
Sobel JD
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
[TBL] [Abstract][Full Text] [Related]
18. Improving quality of antifungal use through antifungal stewardship interventions.
Lachenmayr SJ; Strobach D; Berking S; Horns H; Berger K; Ostermann H
Infection; 2019 Aug; 47(4):603-610. PubMed ID: 30805898
[TBL] [Abstract][Full Text] [Related]
19. Antifungal treatment in haematological and oncological patients: Need for quality assessment in routine care.
Lachenmayr SJ; Berking S; Horns H; Strobach D; Ostermann H; Berger K
Mycoses; 2018 Jul; 61(7):464-471. PubMed ID: 29575106
[TBL] [Abstract][Full Text] [Related]
20. Antifungal stewardship in a tertiary hospital.
Ramos A; Pérez-Velilla C; Asensio A; Ruiz-Antorán B; Folguera C; Cantero M; Orden B; Muñez E
Rev Iberoam Micol; 2015; 32(4):209-13. PubMed ID: 26422321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
